This report is being filed due to access site and plural bleeding, requiring treatment.(b)(6).Patient id: (b)(6).It was reported that on (b)(6) 2023, the patient presented with mitral regurgitation (mr) grade 3-4, an enlarged left atrium and anterior leaflet flail.One mitraclip was successfully implanted, reducing the mr to grade 1+.Post-procedure, access site bleeding was noted.A compression bandage was placed as treatment.On (b)(6) 2023, the patient had worsening dyspnea.Per imaging, a bloody sero-pneumothorax was noted with a shift of the central bronchial of the lower and med lungs.A pleural effusion was reported.As treatment a blood transfusion was provided.The event did not require additional hospitalization.Per physician, the sero-pneumothorax event was possibly related to the steerable guide catheter.There was no device malfunction associated with the device.No additional information was provided regarding this issue.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot.The investigation was unable to determine a cause for the reported pleural effusion and hemorrhage.The dyspnea appears to be a cascading effect of the pleural effusion.Pleural effusion, dyspnea, and hemorrhage are listed in the instructions for use as known possible complications associated with mitraclip procedures.The reported unexpected medical intervention was a result of case specific circumstance.There is no indication of a product issue with respect to manufacture, design, or labeling.
|